The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 31, 2017
Filed:
Mar. 18, 2016
Nicole Buschmann, Basel, CH;
Robin Alec Fairhurst, Allschwil, CH;
Pascal Furet, Thann, FR;
BO Han, Shanghai, CN;
Thomas Knöpfel, Rheinfelden, CH;
Catherine Leblanc, Basel, CH;
LV Liao, Shanghai, CN;
Robert Mah, Muttenz, CH;
Franck Mallet, Basel, CH;
Julie Martz, Colmar, FR;
Can Wang, Suzhou, CN;
Jing Xiong, Shanghai, CN;
Xianglin Zhao, Shanghai, CN;
Nicole Buschmann, Basel, CH;
Robin Alec Fairhurst, Allschwil, CH;
Pascal Furet, Thann, FR;
Bo Han, Shanghai, CN;
Thomas Knöpfel, Rheinfelden, CH;
Catherine Leblanc, Basel, CH;
Lv Liao, Shanghai, CN;
Robert Mah, Muttenz, CH;
Franck Mallet, Basel, CH;
Julie Martz, Colmar, FR;
Can Wang, Suzhou, CN;
Jing Xiong, Shanghai, CN;
Xianglin Zhao, Shanghai, CN;
Novartis AG, Basel, CH;
Abstract
The present invention relates to particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide, to a process of making said particles, to pharmaceutical compositions comprising said particles and to method of treating cancers using said pharmaceutical compositions.